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Abstract
Background: Ultrasound is increasingly used to evaluate shoulder pain, but the benefits of this are unclear. In this
study, we examined whether ultrasound-defined pathologies have implications for clinical outcomes.
Methods: We extracted reported pathologies from 3000 ultrasound scans of people with shoulder pain referred
from primary care. In latent class analysis (LCA), we identified whether individual pathologies clustered in groups.
Optimal group number was determined by the minimum Bayesian information criterion. A questionnaire was sent
to all patients scanned over a 12-month period (n = 2322). Data collected included demographics, treatments
received, current pain and function. The relationship between pathology-defined groups and clinical outcomes was
examined.
Results: LCA revealed four groups: (1) bursitis with limited inflammation elsewhere (n = 1280), (2) bursitis with
extensive inflammation (n = 595), (3) rotator cuff tears (n = 558) and (4) limited pathology (n = 567). A total of 777
subjects (33%) completed questionnaires. The median (IQR) duration post-ultrasound scan was 25 (22–29) months.
Subsequent injections were most common in groups 1 and 2 (groups 1–4 76%, 67%, 48% and 61%, respectively);
surgery was most common in group 3 (groups 1–4 23%, 21%, 28% and 16%, respectively). Shoulder Pain and
Disability Index scores were highest in group 3 (median 48 and 30, respectively) and lowest in group 4 (median
32 and 9, respectively). Patients in group 4 who had surgery reported poor outcomes.
Conclusions: In a community-based population, we identified clusters of pathologies on the basis of ultrasound.
Our retrospective data suggest that these groups have different treatment pathways and outcomes. This requires
replication in a prospective study to determine the value of a pathology-based classification in people with
shoulder pain.
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Background
Shoulder pain is common, with an estimated worldwide
incidence of 0.9% to 2.5% and point prevalence of up to
26% [1]. Importantly for our ageing society, shoulder
pain increases with age, with a prevalence of 21% in
those over 70 years old [2]. In the United Kingdom,
approximately 4% of adults consult their general practi-
tioner (GP) about shoulder pain [3, 4]. Management
remains challenging and often results in poor outcomes.
Despite the short-term beneficial effects of community-
based interventions, 50% of people continue to have pain
at 18 months, though pain can also follow a remitting-
relapsing course over time, making evaluation of treat-
ment at single time points difficult [5, 6]. Shoulder pain
has a significant impact on quality of life, and the
economic burden has been estimated to be €689 per
person annually [7, 8].
The clinical diagnosis of shoulder pathologies is diffi-
cult, and evidence suggests poor levels of reliability and
reproducibility amongst clinicians when examining
shoulder pain [9, 10]. Recent qualitative research has
shown uncertainty amongst GPs in the diagnosis of
patients with shoulder pain [11]. Diagnosis is compli-
cated further by inconsistent nomenclature and classifi-
cations [12]; pathologies of the rotator cuff (RC) have
been described by a variety of terms, including RC
syndrome, shoulder impingement syndrome, subacromial
bursitis and RC tendinitis.
Ultrasound offers accurate detection of pathology, and,
in the context of the reported diagnostic uncertainty, it
is unsurprising that its use is increasing. From 2001 to
2009 in Australia, there was a fourfold rise in shoulder
ultrasound scans [13]. The number of primary care re-
ferrals for shoulder ultrasound scans in a U.K. regional
centre tripled to 3000 between 2007 and 2015 (Leeds
Teaching Hospitals NHS Trust, unpublished data). How-
ever, it is still unclear how information from ultrasound
relates to treatment and long-term outcomes [14, 15]. The
extent to which diagnostic tests on shoulder pain inform
and affect patient management and outcomes has been
highlighted previously in several systematic literature re-
views as an area that needs to be investigated [13, 16].
Shoulder pain may have complex aetiologies, and
pathologies often do not occur in isolation; some may
respond to particular therapies better than others, which
could complicate assessment of efficacy if they co-occur.
Therefore, understanding patterns of shoulder pathology
may help in targeting therapies more effectively. Given
the uncertainty in clinical diagnosis, it seems reasonable
to examine the potential of pathology-based diagnosis
using ultrasound. If ultrasound cannot identify groups of
patients who will achieve different outcomes, either in
the current care pathway or in trials of targeted therap-
ies, there would be limited justification for its continued
use in this patient group. As a first step toward under-
standing the importance of a pathology-based classifica-
tion, we aimed to determine whether distinct clusters of
ultrasound-defined pathologies exist and whether there
is any evidence that these have implications for long--
term clinical outcomes.
Methods
Patients
Ultrasound reports were retrieved for consecutive pri-
mary care patients referred to a single centre’s radiology
department (Chapel Allerton Hospital, Leeds, UK) for a
scan of their shoulder. We included 3000 patients on the
basis of estimated annual referrals and included scans
between 2012 and 2013. Inclusion criteria were that
patients be aged over 18 years, referred from primary
care, referred for shoulder pain and attending for their
first ultrasound scan. Patients were excluded if they had
had previous surgery or had not been referred from pri-
mary care. These patients were identified by details on
the referral card and electronic patient records.
In our centre, guidelines advise that patients be re-
ferred from primary care for an ultrasound scan if they
have moderate-severe painful abduction, have not
improved after physiotherapy or have suspected acro-
mioclavicular joint (ACJ) pain. However, clinical experi-
ence of the broad range of presenting symptoms and
signs raises questions about adherence to these recom-
mendations and may further highlight discrepancies in
clinical evaluation of shoulder pain.
Ultrasound scans
Data from a single shoulder per patient were utilised,
and, where identifiable, the first symptomatic shoulder
was included. Eligible patient records were examined to
identify the first ultrasound scan for a selected shoulder
(even if the first scan fell outside the collection dates).
Scans were obtained by musculoskeletal radiologists and
sonographers. Previous work has shown that inter-rater
reliability for shoulder pathologies between two of the
radiologists is substantial (all κ values >0.6) for full-
thickness RC tear, calcification, impingement and tendon
abnormalities [17]. The following features were docu-
mented as present or absent: bursitis, impingement,
calcific tendinitis, ACJ degeneration, glenohumeral
osteoarthritis, adhesive capsulitis, biceps tenosynovitis,
RC tendinopathy and full or partial RC tear (see
Additional file 1 for definitions). After discussion with
the sonographers, impingement was assumed to be
present if there was a full-thickness RC tear, even if im-
pingement was not reported. Other pathologies were as-
sumed to be absent if not reported. Other details
recorded included age at time of scan, sex, whether an
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injection was given on the day of the scan, and (where
available) duration of pain.
Questionnaire
A postal questionnaire was sent to all eligible patients
scanned in 2013. A second wave of questionnaires was
sent to those who had not replied after 4 weeks. Data
collected included demographics; characteristics of pain;
previous treatment; Shoulder Pain and Disability Index
(SPADI), a validated self-administered questionnaire
used to measure pain and disability in the shoulder in
the past week [18–20]; EuroQol five dimensions scale
(EQ-5D-5 L), a self-report measure used to define health
status [21]; Marx shoulder activity scale [22]; and self-
reported comorbidities. Returned questionnaires were
matched to ultrasound findings.
Statistical analysis
Latent class analysis (LCA) was performed (see
Additional file 1 for full details). LCA identifies clusters
which group together people who share similar charac-
teristics, in this case people who share a distinct pattern
of shoulder pathology. The model calculates the prob-
ability of group membership for each person and assigns
each individual to the group with the highest probability;
the accuracy of the classification can be improved by in-
cluding covariates such as age and sex. The classes we
identified (hereafter groups) were then compared for age,
sex, duration of pain (according to the initial scan rec-
ord), injection (according to the initial scan record) and
the presence of each pathology. To check for responder
bias, these details were also compared between patients
who completed the questionnaire and those who did
not. Questionnaire responses were compared between
the pathology groups using quantile, Poisson or binary
logistic regression, according to the outcome type,
adjusting for age and sex. Appropriate checks were made
that the data satisfied the test assumptions. We used
Stata version 13.1 software (StataCorp, College Station,
TX, USA) for analysis.
Results
To identify 3000 eligible ultrasound scans, 3035 referral
cards were reviewed. Reasons for exclusion included 6
scans technically difficult, 9 scan results inaccessible, 17
with soft tissue lumps examined and 3 with guided pro-
cedures without diagnostic scans.
Ultrasound pathologic findings
In the 3000 patients selected, the mean age was
54.6 years, and 52% were female (Table 1). For eight
patients, impingement could not be assessed owing to
difficulty in moving the patient’s arm; impingement sta-
tus was set to ‘missing’ for these patients. The most
common pathologies were subacromial impingement
(69%) and bursitis (68%), followed by ACJ degeneration
(40%), tendinopathy (36%), calcific tendonitis (12%),
biceps tenosynovitis (7%), glenohumeral osteoarthritis
(6%) and adhesive capsulitis (3%).
Latent class analysis
The LCA suggested four or five groups existed. (For full
details, see Additional file 1: Tables S1–S3.) We retained
the four-group solution. On the basis of patterns of
pathology in each group, we interpreted that they repre-
sented bursitis with limited inflammation elsewhere
Table 1 Demographics and ultrasound findings in patients included in the full scan review and those sent a questionnaire
Full scan review
(n = 3000)
Questionnaire recipients
(n = 2322)
Responders
(n = 777)
Non-responders
(n = 1545)
Age, years, mean (SD) 54.6 (15.1) 54.1 (15.1) 56.4 (13.8) 53.0 (15.6)
Female sex, % 52% 52% 54% 51%
Pain duration, months, median (IQR) 5 (3–9), n = 1165 5 (3–10), n = 868 5 (3–10), n = 292 5 (3–9), n = 576
Steroid injection at time of scan, % 33% 31% 37% 28%
RC tear, % 26% 24% 27% 23%
Full thickness RC tear, % 19% 18% 20% 17%
Bursitis, % 68% 71% 72% 71%
Impingement, % 69% (of 2992) 68% (of 2314) 71% (of 776) 67% (of 1538)
Calcific tendinitis, % 12% 12% 14% 12%
ACJ degeneration, % 40% 45% 48% 43%
Glenohumeral OA, % 6% 5% 5% 6%
Adhesive capsulitis, % 3% 3% 4% 3%
Biceps tenosynovitis, % 7% 9% 9% 9%
Rotator cuff tendinopathy, % 36% 38% 40% 37%
ACJ Acromioclavicular joint, OA Osteoarthritis, RC Rotator cuff
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(group 1), bursitis with extensive inflammation (group
2), RC tears (group 3) and limited pathology (group 4)
(Table 2).
Group 1 was the largest (43%) (Table 2); the other
three groups each represented approximately 20%. The
groups were similar in gender balance or duration of
pain prior to the first scan. Patients in group 4 were the
youngest; 42% had no pathologies recorded, and a fur-
ther 42% had just one pathology reported (Fig. 1). In
group 4, mean age was similar to group 1; all patients in
group 1 had bursitis, but few had tendinopathy or ACJ
degeneration. In group 2, on average 20 years older than
groups 1 and 4, almost all patients had bursitis, RC ten-
dinopathy and ACJ degeneration, and one-fourth had bi-
ceps tenosynovitis. Patients in group 3 were the oldest
on average; all had RC tears, which were full-thickness
tears in the majority. Patients in this group had the high-
est rate of glenohumeral osteoarthritis, as might be ex-
pected for their age, but a smaller proportion in group 3
than in group 2 had ACJ degeneration. Nearly all pa-
tients in group 3 had impingement; however, compara-
tively few had bursitis compared with groups 1 and 2.
Patient questionnaire findings
A postal questionnaire was sent to all eligible patients
scanned in 2013 (n = 2322). Of these patients, 777 com-
pleted questionnaires (33%), and we received replies
from a further 233 (10%) who declined to participate.
Responders and non-responders were similar in gender
balance, age and ultrasound pathology findings (Table 1).
Some respondents reported a diagnosis of rheumatoid
arthritis (RA) (n = 87). Ultrasound findings did not show
intra-articular synovitis in the RA-reporting group. Re-
running the LCA in questionnaire respondents who did
not report having RA (n = 690) resulted in very results
similar to those of the full (n = 3000) LCA (see
Additional file 1: Table S4 for details). We therefore
retained the original pathology groupings; however, in
the analyses of questionnaire outcomes, we excluded
those reporting RA.
Questionnaires were completed by 30%, 36%, 34% and
25% of patients in groups 1–4, respectively. Older
patients were more likely to respond; there were no dif-
ferences in adjusted response rates between groups
(probability of response in group 1 = 0.31 [0.28–0.34],
group 2 = 0.33 [0.29–0.37], group 3 = 0.30 [0.26–0.35],
group 4 = 0.28 [0.23–0.32]; chi-square = 3.04, p = 0.386).
Questionnaire results for all respondents are presented
in Additional file 1: Table S5; 67% still experienced pain
at a median (IQR) of 25 (22–29) months since their
scan. Ultrasound findings by group (restricted to ques-
tionnaire respondents) are provided in Additional file 1:
Table S6. Follow-up duration was similar in the four
groups (Table 3). Between 63% (groups 1 and 2) and
77% (group 3) of patients reported persistent pain at
follow-up.
The most commonly reported painful sites other than
the target shoulder were lower back (36%), neck (33%),
and knees either ipsilateral (27%) or contralateral (24%)
to the target shoulder (Additional file 2: Figure S1).
Table 2 Demographic characteristics and ultrasound pathology findings in each of four pathology groups
Bursitis (limited inflammation)
(n = 1280)
Bursitis (extensive inflammation)
(n = 595)
RC tear
(n = 558)
Limited pathology
(n = 567)
Percentage of sample 43% 20% 18% 19%
Age, years, mean (SD) 47.6 (11.5) 64.2 (10.5) 69.1 (11.2) 46.1 (13.5)
Female sex, % 54 52 51 46
Pain duration, months,a median (IQR) 5 (3–10) 5 (3–9) 5 (3–9) 4 (3–8)
Steroid injection at time of scan, % 44 37 13 26
RC tear, yes/no, % 2 24 100 6
Full-thickness RC tear, % 1 13 86 <1
Bursitis, % 100 94 30 7
Impingement, % 88 65 91 6
Calcific tendinitis, % 14 18 5 9
ACJ degeneration, % 26 83 54 15
Glenohumeral OA, % <1 10 16 2
Adhesive capsulitis, % <1 3 <1 12
Biceps tenosynovitis, % <1 25 10 2
Rotator cuff tendinopathy, % 23 92 24 20
Probability of membership, mean 0.88 0.80 0.89 0.93
ACJ Acromioclavicular joint, OA Osteoarthritis, RC Rotator cuff
an = 507, 198, 233 and 227 in groups 1–4, respectively
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Adjusted estimates of the number of painful sites were
highest in group 2 (mean 4.2) and lowest in group 4
(mean 3.0) (Table 4).
There was descriptive evidence that treatment differed
according to presence of certain individual pathologies
(Additional file 1: Table S7). There were clear differences
in treatment at the group level for steroid injection (p <
0.001) and surgery (p = 0.015) (Table 4). Those in group
1 (bursitis with limited inflammation) were the most
likely to have had steroid injection(s) (adjusted probabil-
ity 76%), whereas those in group 3 (RC tears) were least
likely (49%). Patients in group 3 were the most likely to
have had surgery (35%); surgery was least likely in the
limited pathology group (14%). In patients with bursitis,
those in group 3 were less likely to have received a
steroid injection at time of scan than those in groups 1
and 2 (estimated probability of injection [95% CI] group
1 = 0.48 [0.41, 0.54]; group 2 = 0.41 [0.33, 0.49]; group 3 =
0.20 [0.06, 0.33]; chi-square = 8.6, p = 0.014). Adjusted
rates of physiotherapy did not differ between groups.
Groups differed in the severity of their reported symp-
toms. Group 3 (RC tears) was more likely to still have
pain at follow-up (Table 4), and subjects in this group
reported the highest levels of SPADI pain. A similar
trend was seen for SPADI difficulty scores (Tables 3 and
4; Fig. 2). These trends were not explained by the higher
rate of surgery in group 3; those who had surgery re-
ported lower scores (adjusted difference in median total
score [95% CI] −19 [−38, 0]; z-score = −1.98, p = 0.048).
The differences in total SPADI by surgery were negli-
gible for group 1 (−8 [−22, 5]; z-score = −1.23, p = 0.220)
and group 2 (0 [−17, 17]; z-score = −0.04, p = 0.965). In
contrast, in group 4, total SPADI was substantively
higher in the patients who had surgery (25 [−1, 51]; z-
score = 1.89, p = 0.059) (see Additional file 3: Figure S2).
Patients in group 4 who had surgery were more likely
to report a diagnosis of depression than those who had
not (adjusted probability [95% CI] 0.40 [0.15–0.66] vs.
0.09 [0.02–0.15]), whereas surgery was not associated
with depression in the other groups (interaction effect
for group × surgery chi-square = 9.4, p = 0.025). However,
the nature of the association between symptoms, surgery
and depression cannot be determined in this cross-
sectional study. There were no substantive age- and
sex-adjusted differences between the groups in shoulder
activity level, EQ-5D index score, EQ-5D health VAS
score, the number of comorbidities reported, or the odds
of reporting difficulty standing from sitting (data not
shown).
Discussion
This study has demonstrated, for the first time to our
knowledge, clustering of ultrasound pathologies into
four groups. These groups reported different treatments
and to some extent had different age- and sex-adjusted
outcomes at 2 years; however, owing to the low ques-
tionnaire completion rate, the longitudinal results need
to be interpreted with caution.
Currently, there is limited evidence-based guidance on
the role of imaging in the shoulder pain care pathway,
and international guidance pre-dates the wide availability
of ultrasound [23]. Though guidance for the diagnosis
and management of many common painful musculoskel-
etal problems generally does not require imaging as part
of routine care, the uncertainty in clinical evaluation,
poor patient outcomes and increasing use of ultrasound
support critical evaluation of the usefulness of a
pathology-based classification. Researchers in a recent
pragmatic randomised trial reported no evidence of dif-
ference in patient-perceived recovery between those with
ultrasound-tailored treatment and usual-care groups
Fig. 1 Pathology count by group. RC Rotator cuff, US Ultrasound
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[24]. Ultrasound-guided treatment was targeted at indi-
vidual pathologies, and it would be interesting to see if
outcomes would differ using our novel pathology-based
classification.
The clinical validity of the pathology groups identified
in this study require further evaluation in future studies.
Conceivably, patients with just one pathology may re-
spond differently to treatment compared with patients in
Table 3 Questionnaire outcomes summarised by pathology group, excluding those reporting rheumatoid arthritis (n = 690)
Bursitis (limited inflammation)
(n = 291)
Bursitis (extensive inflammation)
(n = 177)
RC tear
(n = 122)
Limited pathology
(n = 100)
Percentage of sample 40% 39% 33% 42%
Age, years, mean (SD) 49.9 (11.1) 64.8 (9.2) 67.1 (10.4) 47.5 (12.6)
Female sex, % 63 45 47 55
Smoker, % 40 39 33 42
Comorbidity count, median (IQR) 1 (0–2) 2 (1–2) 2 (1–3) 1 (0–2)
Painful sites count (including target), median (IQR) 3 (1–6) 3 (1–7) 3 (1–6) 2 (1–4)
Follow-up, months, median (IQR) 26 (23–29) 26 (22–29) 25 (23–29) 24 (21–26)
Had shoulder fracture before scan, % 2 2 <1 1
Had shoulder dislocation before scan, % 1 – 4 1
Had breast/shoulder cancer before scan, % <1 – – –
Had major injury to target shoulder before scan, % 7 8 18 3
Had shoulder fracture since scan, % <1 1 – 1
Had shoulder dislocation since scan, % <1 – – –
Had breast/shoulder cancer since scan, % <1 <1 – –
Had major injury to target shoulder since scan, % 1 2 7 1
Had physiotherapy since scan, % 65 62 59 58
Had injection since scan, % 76 67 48 61
Had more than one injection since scan, % 33 30 22 24
Had surgery since scan, % 23 21 28 16
Still has shoulder pain, % 63 63 77 64
If still in pain
Pain duration, months, median (IQR) 24 (12–36) 21 (12–36) 25 (12–36) 24 (18–36)
Has pain-free periods, % 70 77 72 77
Experiences pain on moving in a certain way, % 91 93 92 85
If not still in pain
How long since last had pain, months, median
(IQR)
12 (6–17) 13 (12–20) 12 (6–18) 12 (10–20)
How long did pain last, months, median (IQR) 9 (3–15) 9 (5–18) 12 (12–18) 6 (4–12)
Symptoms at time of questionnaire
SPADI pain, median (IQR) 34 (4–62) 26 (2–62) 48 (18–66) 32 (6–64)
SPADI difficulty, median (IQR) 13 (0–45) 14 (0–43) 30 (10–54) 9 (0–38)
SPADI total, median (IQR) 24 (3–52) 21 (3–51) 41 (15–59) 25 (5–49)
Shoulder activity score, median (IQR) 6 (3–10) 6 (3–10) 5 (3–9) 7 (4–11)
EQ-5D health index score, median (IQR) 0.8 (0.6–0.8) 0.7 (0.6–0.8) 0.7 (0.5–0.8) 0.8 (0.7–0.8)
EQ-5D VAS, median (IQR) 80 (55–90) 80 (60–90) 75 (60–80) 80 (70–90)
EQ-5D anxiety or depression (>0), % 34 30 40 29
Depression reported in comorbidity list, % 17 14 18 14
Difficulty standing from sitting (>1), % 16 20 21 10
EQ-5D EuroQol five dimensions scale, SPADI Shoulder Pain and Disability Index, VAS Visual analogue scale
Data were not available for all outcomes for all survey responders; see Additional file 1: Table S8 for numbers of patients with data available
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whom the same pathology co-occurs with other patholo-
gies. Although we did not attempt to examine the effi-
cacy of different treatments, different patterns of
treatment were reported. Group 1 was most likely to re-
ceive steroid injections. Steroid treatment may help with
subacromial bursitis in the short term [25], which may
explain the treatment in this group. Groups 1 and 2 may
represent a spectrum; members of group 2 are older,
and if we were to follow patients similar to those in
group 1 over time, their patterns of shoulder pathology
may eventually resemble those of group 2. Group 3 was
the oldest group, confirming previous studies which
have shown that RC tears increase with age [26]. Mem-
bers of group 3 were less likely to receive steroid injec-
tions, even if they had concurrent bursitis, and they
were more likely to undergo surgery. Steroid injec-
tions may impede tendon repair, and RC tears offer a
surgical target, which may explain the variation in
treatment. Group 3 also had the highest level of
current pain and functional impairment. Surgical
repair techniques of RC tears vary, and surgery has
been shown to have conflicting results in improving
outcomes in patients with shoulder pain [27–29]. Our
data suggest that those who had surgery reported
lower levels of pain and functional impairment.
Group 4 was the youngest group, and a smaller pro-
portion of these patients reported having surgery,
because fewer had detectable pathologies present.
Group 4 also had the lowest levels of pain and
functional disability of all the groups.
Table 4 Age- and sex-adjusted comparisons between pathology groups for key outcomes, excluding those reporting rheumatoid
arthritis (n = 690)
Bursitis (limited inflammation)
(n = 291)
Bursitis (extensive inflammation)
(n = 177)
RC tear
(n = 122)
Limited pathology
(n = 100)
Test result, p value
Number of painful sitesa 4.0 (3.7–4.2) 4.2 (3.9–4.6) 3.6 (3.3–4.0) 3.0 (2.6–3.3) χ2 = 29.0, p < 0.001
Steroid injection at time
of scan
0.49 (0.42–0.55) 0.40 (0.32–0.47) 0.12 (0.06–0.18) 0.34 (0.24–0.44) χ2 = 40.1, p < 0.001
Steroid injection since scan 0.76 (0.70–0.81) 0.67 (0.69–0.75) 0.49 (0.39–0.59) 0.63 (0.52–0.73) χ2 = 20.3, p < 0.001
Physiotherapy 0.59 (0.53–0.66) 0.67 (0.60–0.75) 0.67 (0.58–0.76) 0.53 (0.43–0.63) χ2 = 5.0, p = 0.171
Surgery 0.19 (0.15–0.24) 0.25 (0.18–0.33) 0.35 (0.25–0.46) 0.14 (0.07–0.21) χ2 = 10.5, p = 0.015
Pain at follow-up 0.59 (0.53–0.65) 0.68 (0.61–0.75) 0.81 (0.74–0.88) 0.60 (0.50–0.70) χ2 = 17.3, p < 0.001
SPADI painb 29 (22–36) 32 (23–41) 51 (40–62) 28 (17–40) F(3, 672) = 4.0, p = 0.008
SPADI difficultyb 15 (10–20) 19 (12–25) 31 (23–39) 11 (3–20) F(3, 668) = 4.1, p = 0.006
SPADI totalb 23 (18–29) 25 (18–32) 42 (34–51) 20 (11–29) F(3, 666) = 5.3, p = 0.001
RC Rotator cuff, SPADI Shoulder Pain and Disability Index
All values in the table are adjusted probability of the outcome (95% CI) unless otherwise stated
aAdjusted mean (95% CI)
bAdjusted median (95% CI)
Fig. 2 Shoulder Pain and Disability Index (SPADI) boxplot. RC Rotator cuff
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Many (42%) in group 4 had no pathology; some of
these patients may have improved at the time of their
ultrasound scan. Another explanation is that other path-
ologies were present that ultrasound could not detect.
Ultrasound is as sensitive and specific as magnetic res-
onance imaging (MRI) in detecting RC disorders [30],
but further work is required to understand its sensitivity
and specificity in detecting other pathologies, such as
calcific tendinopathy. Furthermore, pathologies such as
labral tears require MRI for identification [31, 32]. In
addition, imaging-detected pathologies may not correlate
with clinical findings. In the present study, 16% of
patients without detectable pathology received steroid
injections at the time of their scan; many reports docu-
mented that this was after discussion with the patient,
and in some cases because clinical impingement was
suspected even though this was not confirmed by the
scan. A further explanation could be that the pain may
be referred from other regions, such as the neck. The
cause of chronic pain is multifactorial, and other features
apart from imaging pathology play a role in characteris-
ing pain. Psychological factors such as fear avoidance,
depression and poor quality of life can result in worse
pain, function and perceived recovery outcomes [33, 34].
Ultrasound-detected pathologies have previously been
reported in asymptomatic individuals, and further work
is required to understand which factors result in the de-
velopment and progression of symptoms in these indi-
viduals [14, 26, 27, 35].
Although we looked at associations between baseline
pathologies and outcomes, the absence of baseline clin-
ical data means we could not fully evaluate the predict-
ive value of ultrasound. Previous attempts at identifying
predictors of outcomes in people with shoulder pain
have been made [36–40]. Pain characteristics such as
worse baseline pain, duration of pain, concomitant
psychological complaints, other concomitant musculo-
skeletal problems and repetitive shoulder action resulted
in worse outcomes [37, 39–41]. Existing prognostic
models to improve shoulder pain management have yet
to be validated and assessed for clinical utility [39, 42].
There are very limited studies evaluating the prognostic
role of ultrasound in shoulder pain: One suggested that
the absence of subacromial bursa pathology may be a
predictor of excellent outcomes at 3 weeks [36].
This study has a number of limitations. This study was
undertaken in a single centre, though the sample size
was large; the demographics of included patients seem
similar to those of other large community cohorts [4,
43]. There was no control group, limiting our interpret-
ation of pathologies and symptoms. Our local care path-
way recommends that patients over the age of 65 years
with shoulder pain undergo radiography of their shoul-
der, which may result in a channelling bias because
patients with radiographic osteoarthritis may not
undergo ultrasonography. In this study, local recom-
mendations suggested that patients were referred for
an ultrasound scan if they had moderate-severe pain
and were not responding to physiotherapy, which
could have led to selection bias in our cohort. How-
ever, it would seem that this group would likely be
typical of patients with shoulder pain requiring inves-
tigation in potential future care pathways. Although
the radiographers in this study followed a standar-
dised method of performing ultrasonography of
shoulders [44], standardised reporting of all patholo-
gies was not routine, so if pathology was not docu-
mented, it was assumed absent. It is possible that
some pathologies may not have been reported, espe-
cially if lesions that are considered more severe or
clinically relevant are primarily reported. Group 3 had
the highest level of glenohumeral osteoarthritis but a
lower frequency of ACJ degeneration; the latter find-
ing may be a result of non-standardised reporting,
although it may also be an artefact introduced as a
result of the groupings formed on the basis of LCA.
A prospective study using standardised criteria for the
different diagnostic labels is needed. This was a retro-
spective study, so we were unable to explore inter-
reader reliability, especially in partial RC tears, where
authors of a recent review showed that ultrasound
has some difficulty in diagnosing this pathology [30].
Previous work has shown that, for most shoulder
pathologies, the inter-rater reliability for two of the
present sonographers was acceptable [17]. Impinge-
ment was assumed in all patients with complete RC
tears. The patient questionnaire was retrospective,
raising the possibility of recall bias. Only 33% com-
pleted the questionnaires; therefore, there is potential
for selection bias. However, our work suggests that
completers and non-completers were very similar in
demographic characteristics and pathologic findings.
Importantly, though we recorded symptoms around
2 years after an initial scan, we were unable to deter-
mine initial symptoms and subsequent changes. The
prognostic value of a pathology-based classification
needs to be established before consequent treatment
pathways can be explored.
Conclusions
This study demonstrates, for the first time to our know-
ledge, that patients undergoing ultrasound scans for
shoulder pain can be grouped according to pathologic
patterns. Our data suggest that these groups may receive
different treatment and have different outcomes. These
preliminary data support further exploration of the
potential benefits of a pathology-based classification for
shoulder pain.
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